Join this webinar to learn how digital modeling can provide insight and understanding into the development of dry powder inhalers early in the design process to; reduce development times, save costs of physical prototypes and testing, and increase innovation.
Venue:
Virtual
The COVID pandemic has taught us the importance of human upper airway variability and the immense diversity of patient inhalation profiles. This challenge, combined with the complexity of the inhaler and nebulizer design to produce the proper particle size distribution, and the shape of the drug right down to a molecular level, are all factors in enabling the delivery of the correct dose of the right medicine at the right place in the airways.
Computational modeling and simulation demonstrate the powerful insights they can deliver in a time- and cost-effective way to accelerate medical innovation while further increasing patients' safety and comfort. Learn how Ansys solutions can help you accumulate thorough knowledge and digital evidence for developing dry powder inhalers early in the design process to; reduce development times, save costs of physical prototypes and testing, and increase innovation.
Luke Cox, Senior Account Manager and Ralf Kroeger, Lead Application Engineer
